Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(59 sites)

United States

Research Site, Los Angeles, California

Research Site, Baltimore, Maryland

Research Site, Stony Brook, New York

Research Site, Columbus, Ohio

Brazil

Research Site, Ijuí

Research Site, Londrina

Research Site, São Caetano do Sul

Research Site, Vitória

China

Research Site, Anyang

Research Site, Beijing

Research Site, Bengbu

Research Site, Changchun

Research Site, Changsha

Research Site, Chengdu

Research Site, Chongqing

South Korea

Research Site, Namdong-gu

Research Site, Seoul

Taiwan

Research Site, Taichung

Research Site, Taipei

Vietnam

Research Site, Hanoi

Research Site, Ho Chi Minh City